COMMUNIQUÉS West-GlobeNewswire

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
17/03/2025
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic [...]
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
17/03/2025
WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today [...]
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
17/03/2025
VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it has entered into [...]
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
17/03/2025
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 million Transaction expected to close by mid-2025 Upon close of sale of FibroGen China, cash runway extended into 2027 [...]
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
17/03/2025
Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without [...]
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
17/03/2025
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical [...]
BridgeBio Announces CFO Succession
17/03/2025
PALO ALTO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced that Thomas [...]
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
17/03/2025
MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for the fourth quarter and full year ending [...]
SAFE - Signature d’un avenant n°4 au contrat de financement obligataire en vigueur afin de poursuivre le retournement stratégique de Safe
17/03/2025
Avertissement : La société SAFE SA (la « Société ») a mis en place un financement sous forme d’obligations convertibles en actions nouvelles ou existantes (OCEANE) avec Global Corporate Finance Opportunities 20 (« GCFO [...]
Better Choice Company Board of Directors Approves Up to 55% Annual Royalty Distribution Plan from its Halo Brand
17/03/2025
TAMPA, Fla., March 17, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that its Board of Directors have [...]
Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer
17/03/2025
Media Release COPENHAGEN, Denmark; March 17, 2025 Results from Phase 2 RAINFOL TM -01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m 2 led to a confirmed objective response [...]
Recover Red Debuts Innovative PEMF+ Grounding Mat, Transforming At-Home Therapy
17/03/2025
PITTSBURGH, March 17, 2025 (GLOBE NEWSWIRE) -- Recover Red , a leader in advanced wellness technology, has launched the PEMF+ Grounding Mat, a next-generation therapy device designed to revolutionize holistic health. By [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 17 MARCH 2025 at 17.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
New Research Reveals One Million More Glaucoma Cases Than Previously Believed — Glaucoma Research Foundation Urges Early Screening
17/03/2025
Catching glaucoma in its beginning stages can prevent blindness. SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- The Glaucoma Research Foundation (GRF) is launching a national awareness campaign, “Your Eyes Say Thanks [...]
Wellinks and CareAbout Health Partner to Expand Value-Based COPD Management in New Jersey and Florida
17/03/2025
Collaboration Enhances Access to Value-Based Care for COPD Patients NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Wellinks, a digital healthcare company specializing in Chronic Obstructive Pulmonary Disease (COPD [...]
OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants
17/03/2025
Collaboration enhances efficiency and quality in liver recovery and availability OXFORD, United Kingdom and NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., the pioneering company transforming organ [...]
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
17/03/2025
FDA has granted CLPH-511 Fast Track Designation for the treatment of acute hemorrhage as an alternative to conventional platelets when not available or in short supply ROCKVILLE, Md., March 17, 2025 (GLOBE NEWSWIRE) -- [...]
Lytus Technologies announces 24% Revenue Growth for H1 FY2025
17/03/2025
Mumbai, India, March 17, 2025 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT), a leader in platform services and next-generation technology, today announced its consolidated financial results for [...]
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
17/03/2025
--Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease-- --Data Presented at the 2025 Muscular Dystrophy Association (MDA) Conference-- SAN DIEGO, March 17, 2025 (GLOBE [...]

Pages